Amphastar Pharmaceuticals, Inc. (AMPH)

NASDAQ

$19.41

-$0.55 (2.76%)

Today

No price data available for this timeframe.

Key Statistics

Day Range

$19.15$20.26

Open $19.94

52 Week Range

$16.65$31.26

Previous Close $19.96

Market Cap880.09M

Volume991.79K

Avg Volume586.97K

P/E (TTM)11.49

EPS (TTM)$1.75

Dividend / YieldN/A

Dividend StreakN/A

Latest Press Releases for Amphastar Pharmaceuticals, Inc.

JUN82026

Amphastar Pharmaceuticals, Inc. Shareholders Are Encouraged to Reach Out to Johnson Fistel for More Information About Potentially Recovering Their Losses

Source: GlobeNewsWire•9 days ago

SAN DIEGO, June 08, 2026 (GLOBE NEWSWIRE) -- Johnson Fistel, PLLP is investigating whether Amphastar Pharmaceuticals, Inc. (NASDAQ: AMPH) or certain of its executive officers violated federal securities laws. The investigation focuses on investors' l...

MAY272026

Amphastar Pharmaceuticals to Present at the 2026 Jefferies Healthcare Conference

Source: Accesswire•21 days ago

RANCHO CUCAMONGA, CA / ACCESS Newswire / May 27, 2026 / Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) announced today that Bill Peters, CFO, and Jacob Liawatidewi, EVP of Corporate Administration, will be presenting at the 2026 Jefferies Healthcare C...

MAY72026

Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended March 31, 2026

Source: Accesswire•41 days ago

Net revenues of $171.2 million for the three months ended March 31, 2026 GAAP net income of $6.4 million, or $0.14 per share, for the first quarter Adjusted non-GAAP net income of $19.5 million, or $0.42 per share, for the first quarter Company to ho...

MAY62026

Amphastar Pharmaceuticals to Present at the 2026 Bank of America Health Care Conference

Source: Accesswire•42 days ago

RANCHO CUCAMONGA, CA / ACCESS Newswire / May 6, 2026 / Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) announced today that Bill Peters, CFO, and Tony Marrs, EVP of Regulatory Affairs and Clinical Operations, will be presenting at the 2026 Bank of Amer...

APR302026

Amphastar Pharmaceuticals to Release First Quarter Earnings and Hold Conference Call on May 7, 2026

Source: Accesswire•48 days ago

RANCHO CUCAMONGA, CA / ACCESS Newswire / April 30, 2026 / Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) announced today that the Company will release results for its first quarter of 2026, ended March 31, 2026, after the market closes on Thursday, Ma...

APR62026

Amphastar Pharmaceuticals to Present at the 25th Annual Needham Healthcare Conference

Source: Accesswire•72 days ago

RANCHO CUCAMONGA, CA / ACCESS Newswire / April 6, 2026 / Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) ("Amphastar" or the "Company") announced today that Bill Peters, CFO, Tony Marrs, EVP of Regulatory Affairs and Clinical Operations, and Dan Dischn...